Exact Mass: 510.09858220000007
Exact Mass Matches: 510.09858220000007
Found 158 metabolites which its exact mass value is equals to given mass value 510.09858220000007,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
cefuroxime axetil
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Leinamycin
C22H26N2O6S3 (510.09529360000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
2-O-[2-O-(alpha-D-Mannopyranosyl)-alpha-D-glucopyranosyl]-3-phospho-D-glycerate
C15H27O17P (510.09858220000007)
Palmidin A
Palmidin A is found in green vegetables. Palmidin A is from roots of Rheum palmatum (Turkey rhubarb) and from cascara. From roots of Rheum palmatum (Turkey rhubarb) and from cascara. Palmidin A is found in green vegetables.
cefuroxime axetil
Defactinib
C20H21F3N8O3S (510.14093520000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
IB-Meca
Lormetazepam glucuronide
(3R,3R,4R,4R)-rel-(+)-3,3,4,4-Tetrahydro-7,7-dihydroxy-4,4-bis(4-hydroxyphenyl)-[3,3-bi-2H-1-benzopyran]-2,2-dione
Rhuschalcone II
(3R,3S,4R,4R)-rel-(+)-3,3,4,4-Tetrahydro-7,7-dihydroxy-4,4-bis(4-hydroxyphenyl)-[3,3-bi-2H-1-benzopyran]-2,2-dione
(3aR)-7,13-Dihydroxy-1c,3t,8c,10t-tetramethyl-(3ar,10at)-1,3,3a,8,10,10a-hexahydro-2,4,9,11-tetraoxa-dibenzo[bc,kl]coronen-6,14-dion|(3aR)-7,13-dihydroxy-1c,3t,8c,10t-tetramethyl-(3ar,10at)-1,3,3a,8,10,10a-hexahydro-2,4,9,11-tetraoxa-dibenzo[bc,kl]coronene-6,14-dione|Erythroaphin-sl
4-{[6-O-(4-hydroxy-3,5-dimethoxybenzoyl)-beta-D-glucopyranosyl]oxy}-3-methoxy-benzoic acid
C23H26O13 (510.13733460000003)
Aloe-emodin-dianthron|Aloe-emodindianthron|Aloeemodin bianthrone|alpha-Aloeemodin-dianthron
alpha-L-rhamnopyranosyl-(1 -> 6)-beta-D-glucopyranosylbergaptol
C23H26O13 (510.13733460000003)
(3S,4S)-3-(beta-D-glucopyranosyloxymethyl)-3,4-dihydro-5,6,7-trihydroxy-4-(4-hydroxy-3-methoxyphenyl)-1H-[2]benzopyran-1-one
C23H26O13 (510.13733460000003)
3,3,4,5,5,7,8-heptahydroxyl flavone-8-O-beta-D-glucuronopyranoside|floramanoside C
C21H18O15 (510.06456779999996)
4-[(4-hydroxy-4-formyl-3-((4-hydroxyphenyl)ethynyl)biphenyl-2-yl)(4-hydroxyphenyl)methylene]cyclohexa-2,5-dien-1-one|selaginellin O
Citicoline
Donor of choline in biosynthesis of choline-containing phosphoglycerides.
Cys Glu Glu Met
Cys Glu Met Glu
Cys Met Glu Glu
Asp Asp Met Met
Asp Met Asp Met
Asp Met Met Asp
Glu Cys Glu Met
Glu Cys Met Glu
Glu Glu Cys Met
Glu Glu Met Cys
Glu Met Cys Glu
Glu Met Glu Cys
Met Cys Glu Glu
Met Asp Asp Met
Met Asp Met Asp
Met Glu Cys Glu
Met Glu Glu Cys
Met Met Asp Asp
Palmidin A
4-Methyl-3-({6-(methylsulfonyl)-7-[2-(4-morpholinylmethyl)-1,3-th iazol-4-yl]-4-quinolinyl}amino)phenol
C25H26N4O4S2 (510.13953960000003)
8-Chloro-4-[(3-chloro-4-fluorophenyl)amino]-6-({[1-(4-piperidinyl )-1H-1,2,3-triazol-4-yl]methyl}amino)-3-quinolinecarbonitrile
C24H21Cl2FN8 (510.12501779999997)
1H,1H,2H,2H-PERFLUOROOCTYLTRIETHOXYSILANE
C14H19F13O3Si (510.0895819999999)
IB-MECA
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Piclidenoson (IB-MECA) is a first-in-class, orally active and selective A3 adenosine receptor (A3AR) agonist. Piclidenoson exhibits antiproliferative effect and induces apoptosis in different cancer cell types like melanoma, leukemia. Piclidenoson can be used for the research of autoimmune inflammatory diseases and COVID-19[1][2][3][4].
450191S
C21H21Cl3N6O3 (510.07406460000004)
Rilmazafone hydrochloride (450191S) is a benzodiazepine (omega) ligand[1].
Phosphoric trichloride, polymer with 1,3-benzenediol, phenyl ester
2,4-Dinitrophenyl-2-deoxy-2-fluoro-beta-D-cellobioside
C18H23FN2O14 (510.11332699999997)
N-[[3-(4-methylphenyl)sulfonyl-2-oxazolidinyl]methyl]-N-[2-(4-sulfamoylphenyl)ethyl]oxamide
Citicoline sodium
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents
Defactinib
C20H21F3N8O3S (510.14093520000006)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Lormetazepam glucuronide
Zinnat
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
(2S,3R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide
3-L-tyrosyl-AMP
An L-tyrosyl ester obtained by formal condensation of the carboxy group of L-tyrosine with the 3-hydroxy group of AMP.
bis[2-(3-chloro-4-methoxyanilino)-2-oxoethyl] (E)-but-2-enedioate
4-chloro-2-[5-[(Z)-[5-oxo-3-phenyl-1-(4-propan-2-ylphenyl)pyrazol-4-ylidene]methyl]furan-2-yl]benzoic acid
C30H23ClN2O4 (510.13462680000004)
(5E)-3-(4-ethoxyphenyl)-5-(3-hydroxy-4-methoxybenzylidene)-2-(3-nitrophenyl)-1,3-thiazolidin-4-one 1,1-dioxide
3,4,5-Trihydroxy-6-[[3,6,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxo-2,3-dihydrochromen-5-yl]oxy]oxane-2-carboxylic acid
6-({2-[2,5-dihydroxy-4-(methoxymethyl)phenyl]-3,5-dihydroxy-3,4-dihydro-2H-1-benzopyran-7-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
C23H26O13 (510.13733460000003)
3,4,5-Trihydroxy-6-[2-hydroxy-4-(3,5,7-trihydroxy-6-methoxy-4-oxo-2,3-dihydrochromen-2-yl)phenoxy]oxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[3-hydroxy-4-(4-methoxy-7-oxouro[3,2-g]chromen-9-yl)oxy-2-methylbutan-2-yl]oxyoxane-2-carboxylic acid
C23H26O13 (510.13733460000003)
2-O-[alpha-D-mannopyranosyl-(1->2)-alpha-D-glucopyranosyl]-3-O-phospho-D-glyceric acid
C15H27O17P (510.09858220000007)
3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide
Citicoline (sodium)
Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects. Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects.
8-hydroxy-4-(hydroxymethyl)-9-(1h-indol-3-yl)-5-methyl-4,7-bis(methylsulfanyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione
C25H26N4O4S2 (510.13953960000003)
[7,8-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-hexahydro-2h-pyrano[2,3-b][1,4]dioxin-6-yl]methyl 3,4,5-trihydroxybenzoate
C23H26O13 (510.13733460000003)
(2e)-1-{5'-[(1e)-3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]-2',4,6-trihydroxy-[1,1'-biphenyl]-3-yl}-3-(4-hydroxyphenyl)prop-2-en-1-one
(2e)-1-(2,4-dihydroxyphenyl)-3-(3-{4-[(1e)-3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]phenoxy}-4-hydroxyphenyl)prop-2-en-1-one
1-(5-{4-[3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]phenoxy}-2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one
(2e)-3-[(2s,3s)-3-(2,4-dihydroxybenzoyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl]-1-(2,4-dihydroxyphenyl)prop-2-en-1-one
aloeemodin bianthrone
{"Ingredient_id": "HBIN015288","Ingredient_name": "aloeemodin bianthrone","Alias": "(9S)-2,2'-Bis(hydroxymethyl)-4,4',5,5'-tetrahydroxy-9,9',10,10'-tetrahydro-9alpha,9'alpha-bianthracene-10,10'-dione","Ingredient_formula": "C30H22O8","Ingredient_Smile": "C1=CC2=C(C(=C1)O)C(=O)C3=C(C2C4C5=C(C(=CC=C5)O)C(=O)C6=C4C=C(C=C6O)CO)C=C(C=C3O)CO","Ingredient_weight": "510.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14253","TCMID_id": "968","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11706168","DrugBank_id": "NA"}
2-methoxy-3-({3,4,5-trihydroxy-6-[(4-hydroxy-3,5-dimethoxybenzoyloxy)methyl]oxan-2-yl}oxy)benzoic acid
C23H26O13 (510.13733460000003)
(9z,13z,15z)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
7-hydroxy-3-[7-hydroxy-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1-benzopyran-3-yl]-4-(4-hydroxyphenyl)-3,4-dihydro-1-benzopyran-2-one
(+)-glucose; 6,7,8-trihydroxy-3,5-dimethoxy-2-phenylchromen-4-one
C23H26O13 (510.13733460000003)
3-{5-[(1e)-3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]-2-hydroxyphenyl}-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(3s,4s)-5,6,7-trihydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3,4-dihydro-2-benzopyran-1-one
C23H26O13 (510.13733460000003)
(2z)-n-[(6r,7r)-2-{[1-(acetyloxy)ethoxy]carbonyl}-3-[(c-hydroxycarbonimidoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]-2-(furan-2-yl)-2-(methoxyimino)ethanimidic acid
(2e)-1-(5-{4-[(1e)-3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]phenoxy}-2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one
7-hydroxy-3-[7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-3-yl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
(9s,9's)-2,2',4,4',5,5'-hexahydroxy-7,7'-dimethyl-9h,9'h-[9,9'-bianthracene]-10,10'-dione
1-(3,4-dihydroxyphenyl)-3-[2-(3,4-dihydroxyphenyl)-3-hydroxyoxiran-2-yl]-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-1-one
C23H26O13 (510.13733460000003)
[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 2,3-dihydroxybenzoate
C23H26O13 (510.13733460000003)
(9r,9's)-4,4',5,5'-tetrahydroxy-2,2'-bis(hydroxymethyl)-9h,9'h-[9,9'-bianthracene]-10,10'-dione
3-[1-(2,4-dihydroxyphenyl)-3,3-bis(4-hydroxyphenyl)-1-oxopropan-2-yl]-7-hydroxychromen-4-one
3,4,5-trihydroxy-6-[(1-hydroxy-8-methoxy-3-methyl-7,12-dioxotetraphen-2-yl)oxy]oxane-2-carboxylic acid
C26H22O11 (510.11620619999997)
4,5-dihydroxy-6-[6-hydroxy-3'-(4-hydroxyphenyl)-dihydro-5h-spiro[furo[3,2-b]furan-3,2'-oxolane]-2,5'-dioneoxy]-2-methyloxan-3-yl acetate
C23H26O13 (510.13733460000003)
4,11-dihydroxy-12-{11-hydroxy-10-oxo-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-12-yl}-8,16-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaen-10-one
(1r,4s,7s,8s,9r)-8-hydroxy-4-(hydroxymethyl)-9-(1h-indol-3-yl)-5-methyl-4,7-bis(methylsulfanyl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-10,12,14-triene-3,6-dione
C25H26N4O4S2 (510.13953960000003)
6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione
C21H22N2O9S2 (510.07666820000003)
10',11',14'-trihydroxy-7-methoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione
3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxy-3,5-dimethoxybenzoyloxy)methyl]oxan-2-yl]oxy}benzoic acid
C23H26O13 (510.13733460000003)
(1r,2r,13s,14r,15r,16r,17r,28r)-8,14,23,28-tetrahydroxy-6,21-dimethyloctacyclo[14.11.1.0²,¹¹.0²,¹⁵.0⁴,⁹.0¹³,¹⁷.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-4,6,8,11,19,21,23,26-octaene-3,10,18,25-tetrone
4-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl)oxy]furo[3,2-g]chromen-7-one
C23H26O13 (510.13733460000003)
(3s,4s)-7-hydroxy-3-[(3s,4s)-7-hydroxy-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1-benzopyran-3-yl]-4-(4-hydroxyphenyl)-3,4-dihydro-1-benzopyran-2-one
4,4',5,5'-tetrahydroxy-2,2'-bis(hydroxymethyl)-9h,9'h-[9,9'-bianthracene]-10,10'-dione
(1r,5s,6r,9r,10s,12r,15r)-6,9,10-trihydroxy-19,20-dimethoxy-23-methyl-4,22-dioxa-13,14-dithia-3,23-diazahexacyclo[10.10.2.0¹,¹⁵.0³,¹².0⁵,¹⁰.0¹⁶,²¹]tetracosa-7,16,18,20-tetraene-2,24-dione
C21H22N2O9S2 (510.07666820000003)
(2z)-3-[3-(2,4-dihydroxybenzoyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-5-yl]-1-(2,4-dihydroxyphenyl)prop-2-en-1-one
[6-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-3,4,5-trihydroxyoxan-2-yl]methyl 2,3-dihydroxybenzoate
C23H26O13 (510.13733460000003)
2-(4-hydroxyphenyl)naphthalene-1-carbonyl 2-(4-hydroxyphenyl)naphthalene-1-carboxylate
3-methoxy-4-({3,4,5-trihydroxy-6-[(4-hydroxy-3,5-dimethoxybenzoyloxy)methyl]oxan-2-yl}oxy)benzoic acid
C23H26O13 (510.13733460000003)
(2r,3r,4r,5r,6s)-6-[(3s,3'r,3ar,6s,6ar)-6-hydroxy-3'-(4-hydroxyphenyl)-dihydro-5h-spiro[furo[3,2-b]furan-3,2'-oxolane]-2,5'-dioneoxy]-4,5-dihydroxy-2-methyloxan-3-yl acetate
C23H26O13 (510.13733460000003)
(2s,3r)-7-hydroxy-3-[(2s,3r)-7-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydro-1-benzopyran-3-yl]-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzopyran-4-one
[(2s,3s,4as,6r,7s,8s,8ar)-7,8-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-hexahydro-2h-pyrano[2,3-b][1,4]dioxin-6-yl]methyl 3,4,5-trihydroxybenzoate
C23H26O13 (510.13733460000003)
(1'r,2r,3'r,6s,9e,11r,13z,15e)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
2,2',4,4',5,5'-hexahydroxy-7,7'-dimethyl-9h,9'h-[9,9'-bianthracene]-10,10'-dione
3-[(2r)-1-(2,4-dihydroxyphenyl)-3,3-bis(4-hydroxyphenyl)-1-oxopropan-2-yl]-7-hydroxychromen-4-one
(2r,3'r,6r,9e,11r,13e,15z)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
8,14,23,28-tetrahydroxy-6,21-dimethyloctacyclo[14.11.1.0²,¹¹.0²,¹⁵.0⁴,⁹.0¹³,¹⁷.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-4,6,8,11,19,21,23,26-octaene-3,10,18,25-tetrone
(2r,3'r,6r,9z,11r,13z,15e)-3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
1-{5'-[3-(2,4-dihydroxyphenyl)-3-oxoprop-1-en-1-yl]-2',4,6-trihydroxy-[1,1'-biphenyl]-3-yl}-3-(4-hydroxyphenyl)prop-2-en-1-one
(9r,9'r)-2,2',4,4',5,5'-hexahydroxy-7,7'-dimethyl-9h,9'h-[9,9'-bianthracene]-10,10'-dione
(3s,4s)-7-hydroxy-3-[(3r,4s)-7-hydroxy-4-(4-hydroxyphenyl)-2-oxo-3,4-dihydro-1-benzopyran-3-yl]-4-(4-hydroxyphenyl)-3,4-dihydro-1-benzopyran-2-one
(2s)-1-(3,4-dihydroxyphenyl)-3-[(2s,3s)-2-(3,4-dihydroxyphenyl)-3-hydroxyoxiran-2-yl]-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-1-one
C23H26O13 (510.13733460000003)
3-[3-(2,4-dihydroxybenzoyl)-2-(4-hydroxyphenyl)-1-benzofuran-5-yl]-1-(2,4-dihydroxyphenyl)propan-1-one
(1's,2r,3r,8'r,10's,11'r,14'r)-10',11',14'-trihydroxy-7-methoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(1-hydroxy-8-methoxy-3-methyl-7,12-dioxotetraphen-2-yl)oxy]oxane-2-carboxylic acid
C26H22O11 (510.11620619999997)
3',4,11-trihydroxy-2,3',9-trimethyl-4',12-dioxo-19-thia-3,20-diazaspiro[bicyclo[15.2.1]icosane-6,2'-[1,5]dithiolane]-1(20),3,9,13,15,17-hexaen-1'-ium-1'-olate
C22H26N2O6S3 (510.09529360000005)
2-methoxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxy-3,5-dimethoxybenzoyloxy)methyl]oxan-2-yl]oxy}benzoic acid
C23H26O13 (510.13733460000003)
4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}furo[3,2-g]chromen-7-one
C23H26O13 (510.13733460000003)